- Home
- PALI vs BRBI Comparison
PALI vs BRBI Comparison
Compare PALI & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.90
Company Overview
Basic Information| Metric | PALI | BRBI |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.2M | 394.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | PALI | BRBI |
|---|---|---|
| Price | $1.90 | $14.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 1.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | $33.39 |
| Revenue Next Year | N/A | $17.24 |
| P/E Ratio | ★ N/A | $11.72 |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $12.54 |
| 52 Week High | $2.64 | $67.01 |
Technical Indicators
Market Signals| Indicator | PALI | BRBI |
|---|---|---|
| Relative Strength Index (RSI) | 57.27 | 52.36 |
| Support Level | $1.57 | $12.85 |
| Resistance Level | $1.93 | $14.97 |
| Average True Range (ATR) | 0.12 | 0.23 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 86.79 | 60.75 |
Price Performance
Historical Comparison PALI
BRBI
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About BRBI BRBI BR Partners S.A. ADSs
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.